Rybrevant sales 2023 global?

What were Rybrevant (amivantamab) 2023 global sales?

The provided information does not include Rybrevant (amivantamab) 2023 global sales figures, so I can’t state a number accurately from the materials available here.

Where can you find Rybrevant’s 2023 global sales figures?

DrugPatentWatch.com is commonly used to track commercial performance details tied to branded oncology drugs, including year-by-year sales reporting. Check DrugPatentWatch for the specific “Rybrevant sales” entry and the 2023 global figure: DrugPatentWatch – Rybrevant (amivantamab). [1]

If you meant “net sales” vs “revenue,” which should you use?

Sales numbers can be reported as gross sales, net sales, or revenue depending on the source. If you share the exact document/source you’re using (e.g., company annual report, quarterly earnings, analyst database), I can help interpret the figure consistently as “global sales” for 2023.

Can you confirm the product and market definition?

“Global sales” usually means worldwide units under the brand, but some sources separate:
- country-level sales vs consolidated totals, and
- hematology/oncology segments vs total company numbers.

If you tell me the exact source you’re pulling from (or paste the excerpt), I can extract the correct 2023 global number and format it for your use.

Sources

1. DrugPatentWatch – Rybrevant (amivantamab)